Evolving a national clinical trials learning health system
- PMID: 37066100
- PMCID: PMC10091198
- DOI: 10.1002/lrh2.10327
Evolving a national clinical trials learning health system
Abstract
Clinical trials generate key evidence to inform decision making, and also benefit participants directly. However, clinical trials frequently fail, often struggle to enroll participants, and are expensive. Part of the problem with trial conduct may be the disconnected nature of clinical trials, preventing rapid data sharing, generation of insights and targeted improvement interventions, and identification of knowledge gaps. In other areas of healthcare, a learning health system (LHS) has been proposed as a model to facilitate continuous learning and improvement. We propose that an LHS approach could greatly benefit clinical trials, allowing for continuous improvements to trial conduct and efficiency. A robust trial data sharing system, continuous analysis of trial enrollment and other success metrics, and development of targeted trial improvement interventions are potentially key components of a Trials LHS reflecting the learning cycle and allowing for continuous trial improvement. Through the development and use of a Trials LHS, clinical trials could be treated as a system, producing benefits to patients, advancing care, and decreasing costs for stakeholders.
Keywords: clinical trials; continuous improvement; learning cycle; learning health system.
© 2022 The Authors. Learning Health Systems published by Wiley Periodicals LLC on behalf of University of Michigan.
Conflict of interest statement
The authors declare no potential conflict of interest.
References
-
- Denburg A, Rodriguez‐Galindo C, Joffe S. Clinical trials infrastructure as a quality improvement intervention in low‐ and middle‐income countries. Am J Bioeth. 2016;16:3‐11. - PubMed
-
- Grand View Research . Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, By Region, And Segment Forecasts 2021–2028; 2021. https://www.grandviewresearch.com/industry-analysis/global-clinical-tria.... Accessed 30 July, 2021.
-
- Stensland KD, McBride RB, Latif A, et al. Adult cancer clinical trials that fail to complete: an epidemic? J Natl Cancer Inst. 2014;106. - PubMed
-
- Stensland K, Kaffenberger S, Canes D, Galsky M, Skolarus T, Moinzadeh A. Assessing genitourinary cancer clinical trial accrual sufficiency using archived trial data. JCO Clin Cancer Inform. 2020;4:614‐622. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
